LAURENCE LUM: Open Payments
NPI 1932193554 · DESLOGE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,155 in 182 payments from 38 companies in 2025. Trend: 2023 $3,058 · 2024 $3,641 · 2025 $3,155
Food & beverage: $3,018Education: $137
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $594 |
| Aimmune Therapeutics, Inc. | 12 | $214 |
| Teva Pharmaceuticals USA, Inc. | 9 | $177 |
| Vanda Pharmaceuticals Inc. | 10 | $164 |
| Axsome Therapeutics, Inc. | 2 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $158 |
| GlaxoSmithKline, LLC. | 11 | $135 |
| Lilly USA, LLC | 6 | $126 |
| Merck Sharp & Dohme LLC | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
Products named: QULIPTA, ZENPEP, VRAYLAR, REXULTI, Auvelity, CAPLYTA, FANAPT, TRELEGY ELLIPTA.
Industry payments across MO — which companies pay providers there.
